• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

己糖胺酶A缺乏状态下的GM2神经节苷脂代谢:通过向成纤维细胞培养物中添加标记的GM2进行原位测定。

GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.

作者信息

Raghavan S S, Krusell A, Krusell J, Lyerla T A, Kolodny E H

出版信息

Am J Hum Genet. 1985 Nov;37(6):1071-82.

PMID:2934978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1684734/
Abstract

To clarify the relationship between hexosaminidase A (HEX A) activity and GM2-ganglioside hydrolysis in atypical clinical situations of HEX A deficiency, we have developed a simple method to assess GM2-ganglioside metabolism in cultured fibroblasts utilizing GM2 labeled with tritium in the sphingosine portion of the molecule. The radioactive lipid is added to the media of cultured skin fibroblasts, and after 10 days the cells are thoroughly washed, then harvested, and their lipid composition analyzed by HPLC. The degree of hydrolysis of the ingested GM2 is determined by comparing the amount of radioactive counts recovered in undegraded substrate with total cellular radioactivity. A deficiency in GM2-ganglioside hydrolysis was demonstrated in seven HEX A-deficient adults with neurological signs and in two healthy-appearing adolescents with older affected siblings. In each case, an analysis of endogenous monosialoganglioside composition revealed an increase in GM2-ganglioside, confirming the presence of a block in the metabolism of GM2. No defect in GM2-catabolism was found in four other healthy individuals with HEX A deficiency. This method of assay is especially helpful in the evaluation of atypical cases of HEX A deficiency for the definitive diagnosis of GM2-gangliosidosis.

摘要

为了阐明在己糖胺酶A(HEX A)缺乏的非典型临床情况下己糖胺酶A活性与GM2神经节苷脂水解之间的关系,我们开发了一种简单的方法,利用分子中鞘氨醇部分用氚标记的GM2来评估培养的成纤维细胞中GM2神经节苷脂的代谢。将放射性脂质添加到培养的皮肤成纤维细胞培养基中,10天后将细胞彻底洗涤,然后收获,并通过高效液相色谱法分析其脂质组成。通过比较未降解底物中回收的放射性计数与总细胞放射性来确定摄入的GM2的水解程度。在7名有神经症状的HEX A缺乏成年患者和2名外表健康但有患病年长同胞的青少年中,证实存在GM2神经节苷脂水解缺陷。在每种情况下,对内源性单唾液酸神经节苷脂组成的分析显示GM2神经节苷脂增加,证实存在GM2代谢障碍。在其他4名HEX A缺乏的健康个体中未发现GM2分解代谢缺陷。这种检测方法在评估HEX A缺乏的非典型病例以明确诊断GM2神经节苷脂贮积症方面特别有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fae/1684734/3b5ddcc529fd/ajhg00162-0030-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fae/1684734/3b5ddcc529fd/ajhg00162-0030-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fae/1684734/3b5ddcc529fd/ajhg00162-0030-a.jpg

相似文献

1
GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.己糖胺酶A缺乏状态下的GM2神经节苷脂代谢:通过向成纤维细胞培养物中添加标记的GM2进行原位测定。
Am J Hum Genet. 1985 Nov;37(6):1071-82.
2
Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.培养成纤维细胞的神经节苷脂负载:一种用于诊断GM2神经节苷脂沉积症的激发方法。
Clin Chim Acta. 1986 Apr 15;156(1):41-9. doi: 10.1016/0009-8981(86)90177-4.
3
Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.检测皮肤成纤维细胞中GM2神经节苷脂裂解己糖胺酶活性以诊断GM2神经节苷脂贮积症。
Clin Chim Acta. 1983 Nov 30;135(1):89-93. doi: 10.1016/0009-8981(83)90392-3.
4
Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.青少年GM2神经节苷脂沉积症(AMB变异型):无法通过激活蛋白激活己糖胺酶A。
Am J Hum Genet. 1983 Jul;35(4):551-64.
5
The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.人类GM2激活蛋白。β-己糖胺酶A的一种底物特异性辅助因子。
J Biol Chem. 1991 Jan 25;266(3):1879-87.
6
GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.培养的人皮肤成纤维细胞中GM2神经节苷脂代谢:GM2神经节苷脂沉积症的确切诊断
Biochim Biophys Acta. 1985 Apr 25;834(2):238-48. doi: 10.1016/0005-2760(85)90161-4.
7
Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.以[3H]N-乙酰神经氨酸标记的GM2神经节苷脂为底物诊断泰-萨克斯病。
Clin Chim Acta. 1982 Apr 23;120(3):331-40. doi: 10.1016/0009-8981(82)90374-6.
8
Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.神经节苷脂GM2 N-乙酰-β-D-半乳糖胺酶和脱唾液酸GM2(GA2)N-乙酰-β-D-半乳糖胺酶;对人皮肤成纤维细胞的研究。
Clin Genet. 1977 Mar;11(3):171-83. doi: 10.1111/j.1399-0004.1977.tb01296.x.
9
Plasma G ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis.血浆 G 神经节苷脂可能成为 GM2 神经节苷脂贮积症的诊断、预后和疾病监测的生物标志物。
Mol Genet Metab. 2023 Feb;138(2):106983. doi: 10.1016/j.ymgme.2022.106983. Epub 2022 Dec 26.
10
[Recent advances in molecular genetics of GM2 gangliosidosis].[GM2神经节苷脂贮积症分子遗传学的最新进展]
Nihon Rinsho. 1995 Dec;53(12):2988-93.

引用本文的文献

1
Clinical and genetic characteristics and prenatal diagnosis of patients presented GDD/ID with rare monogenic causes.表现为全球发育迟缓/智力障碍且病因罕见的单基因疾病患者的临床、遗传特征及产前诊断
Orphanet J Rare Dis. 2020 Nov 11;15(1):317. doi: 10.1186/s13023-020-01599-y.
2
G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.黏脂贮积症IV型成纤维细胞中G(M2)神经节苷脂的原位代谢
Neurochem Res. 1999 Apr;24(4):475-9. doi: 10.1023/a:1022523527283.
3
A third mutation at the CpG dinucleotide of codon 504 and a silent mutation at codon 506 of the HEX A gene.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
A new variant of type-AB GM2-gangliosidosis.AB型GM2神经节苷脂贮积症的一种新变体。
Biochem Biophys Res Commun. 1981 Jul 30;101(2):479-85. doi: 10.1016/0006-291x(81)91285-7.
3
A protein activator for the enzymic hydrolysis of GM2 ganglioside.一种用于GM2神经节苷脂酶促水解的蛋白质激活剂。
己糖胺酶A基因第504密码子的CpG二核苷酸处的第三次突变以及第506密码子处的沉默突变。
Am J Hum Genet. 1991 Jun;48(6):1139-46.
4
Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.
Hum Genet. 1992 Mar;88(5):513-23. doi: 10.1007/BF00219337.
J Biol Chem. 1981 Jun 25;256(12):6234-40.
4
The clinical spectrum of hexosaminidase deficiency diseases.己糖胺酶缺乏症疾病的临床谱
Neurology. 1981 Nov;31(11):1453-6. doi: 10.1212/wnl.31.11.1453.
5
Nonuniform deficiency of hexosaminidase A in tissues and fluids of two unrelated individuals.两名无亲缘关系个体的组织和体液中己糖胺酶A的非均匀性缺乏。
Pediatr Res. 1982 Mar;16(3):232-7. doi: 10.1203/00006450-198203000-00014.
6
Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.成纤维细胞中溶酶体酶的生物合成。以高分子量前体形式合成。
J Biol Chem. 1980 May 25;255(10):4937-45.
7
The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.正常人脑及三种类型GM2神经节苷脂沉积症患者脑内对GM2神经节苷脂进行酶促水解的特异性蛋白质激活剂。
J Neurochem. 1983 Jan;40(1):168-75. doi: 10.1111/j.1471-4159.1983.tb12667.x.
8
Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.利用天然激活蛋白检测人成纤维细胞中神经节苷脂GM2-N-乙酰-β-D-半乳糖苷酶活性——GM2神经节苷脂贮积症变异型的诊断
Clin Chim Acta. 1980 Dec 22;108(3):361-8. doi: 10.1016/0009-8981(80)90342-3.
9
Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.晚期婴儿型和成人型GM2神经节苷脂沉积症患者以及己糖胺酶水平较低的健康先证者的培养成纤维细胞中的神经节苷脂GM2 N-乙酰-β-D-半乳糖苷酶活性。
Am J Hum Genet. 1983 Sep;35(5):900-13.
10
Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype.成人GM2神经节苷脂贮积症合并泰-萨克斯病:一种新的表型。
Neurology. 1981 Nov;31(11):1397-1401. doi: 10.1212/wnl.31.11.1397.